Figure S1 from PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
Vaishnavi Sambandam(National Comprehensive Cancer Network), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Qiuli Li(Lanzhou University of Finance and Economics), Tuhina Mazumdar(The University of Texas MD Anderson Cancer Center), Chenfei Huang(Baylor College of Medicine), Curtis R. Pickering(The University of Texas MD Anderson Cancer Center), Xiayu Rao(The University of Texas MD Anderson Cancer Center), Mitchell J. Frederick(Baylor College of Medicine), Li Shen(Sun Yat-sen University), Jing Wang(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center), Jeffery N. Myers(The University of Texas MD Anderson Cancer Center), Shaohua Peng(Sinochem Group (China)), Ratnakar Singh(University of Illinois Urbana-Champaign)
Cited by 0
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Identification of common variants associated with human hippocampal and intracranial volumes
|Nature Genetics|2012|659
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502
Advances and Trends in Omics Technology Development
|Frontiers in Medicine|2022|494